Method for preparing high-yield and high-purity Iguratimod intermediate
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- YANGTZE RIVER PHARM GRP CO LTD
- Publication Date
- 2018-09-28
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of medicine preparation, in particular, the invention relates to a high-yield and high-purity intermediate of iguratimod, namely 3-bromo-7-methanesulfonamide-6-phenoxy-4H-1-benzene The preparation method of -2,3-dihydropyran-4-one. Background technique
[0002] Iguratimod's generic name: Iguratimod, chemical name: N-[3-(formamido)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl]- Methanesulfonamide, English name: N-[3-(formylamino)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl]-methanesulfona mide, is a therapeutic class developed by Japan Toyama Company Drugs for rheumatoid arthritis and osteoarthritis.
[0003] In the published materials, there are few reports on the preparation process of iguratimod. Basically, 4-chloro-3-nitroanisole is used as the starting material to prepare iguratimod through multi-step reactions. Wherein there are 3 routes using bromination reaction to prepare 3-bromo-7-methanesulfonamide-6-phenoxy-4H-1-benzo-...